the pharmaceutical business
TRANSCRIPT
Amount U.S. Pays for patented drugs 2003 compared to:
Source: Health Reform Program Calculations from Patented Prices Review Board reports (Trends in Drug Prices and Expenditures tables) Based on formulary of 1,000+ patent drugs
Sweden
Britain
Germany
Canada
Switzerland
France
Italy
58%
63%
73%
75%
87%108%
118%
Consumer Perspective on Safety, Effectiveness & Cost
9
“A drug that one cannot afford is neither safe nor effective.”
-- Stephen W. Schondelmeyer PRIME Institute, 1996